Clinical Trial Update: Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing induction versus adjuvant gemcitabine/cisplatin in locally advanced non-metastatic nasopharyngeal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• gemcitabine/cisplatin

Snippet

Sponsor: Kuwait Cancer Control Center | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING